On June 23, 2025, Frank Wu, founder and other specialists of Shanghai United Cell Biotech (PRC) – an international biopharmaceutical company that combines the entire production cycle of high-quality innovative and generic biological drugs: from research and development to production, as well as representatives of NN INVEST (RK), which provides consulting services to foreign companies in the markets of Kazakhstan and Central Asia visited the OtarBioPharm LLP biopharmaceutical plant to inspect the biopharmaceutical plant to explore the possibility of cooperation.

Accompanied by Z.D. Yershebulov, General Director of the Partnership, the guests inspected the production units and quality control laboratories of the plant.

After that, the Chinese side presented the company and then the parties discussed plans for cooperation.

As a result of the meeting, the parties to the meeting came to the conclusion that the possibility of bilateral cooperation is quite feasible.